Work

Supplementary Table 1 from Rationale and Preclinical Efficacy of a Novel Anti-EMP2 Antibody for the Treatment of Invasive Breast Cancer

Year: 2023

Type: supplementary-materials

Abstract: PDF - 59K, Known Profile of EMP2 Upregulation in Breast Cancer.

DOI: 10.1158/1535-7163.22499973.v1

Authors: Maoyong Fu, Erin L. Maresh, Gustavo F. Helguera, Meagan Kiyohara, Yu Qin, Negin Ashki, Tracy R. Daniels-Wells, Najib Aziz, Lynn K. Gordon, Jonathan Braun, Yahya Elshimali, Robert A. Soslow, Manuel L. Penichet, Lee Goodglick, Madhuri Wadehra

Language: English

Topic: Monoclonal and Polyclonal Antibodies Research

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362494115

Cites: 7

Cited by:

Related to: 10